A deletion and point mutation study of the human papillomavirus type 16 major capsid gene (Q40238745)

18 September 2017

A deletion and point mutation study of the human papillomavirus type 16 major capsid gene (English)

1 reference

18 September 2017

2

Anna-Lise Williamson

0 references

Edward Rybicki

object named as

Edward P Rybicki

series ordinal

4

0 references

Arvind Varsani

series ordinal

1

object named as

Arvind Varsani

1 reference

18 September 2017

Mohamed A Jaffer

3

1 reference

PubMed ID

16938363

18 September 2017

language of work or name

1 reference

30 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

122

1 reference

18 September 2017

1-2

1 reference

18 September 2017

154-163

1 reference

The influence of virus structure on antibody responses and virus serotype formation

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Classification of papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

A controlled trial of a human papillomavirus type 16 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Chimeric papillomavirus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

NHPV16 VLP vaccine induces human antibodies that neutralize divergent variants of HPV16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Self-assembly and protein-protein interactions between the SV40 capsid proteins produced in insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Human papillomavirus type 16 DNA sequence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Cervical cancer vaccines: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

A monoclonal antibody against intact human papillomavirus type 16 capsids blocks the serological reactivity of most human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

7 January 2021

Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

7 January 2021

Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

7 January 2021

Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

7 January 2021

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

7 January 2021

Characterization of a major neutralizing epitope on human papillomavirus type 16 L1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

7 January 2021

Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.07.012

7 January 2021

10.1016/J.VIRUSRES.2006.07.012

Identifiers

DOI

1 reference

release_hqkgtoimqrbwbmblkk6aguod2i

18 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hqkgtoimqrbwbmblkk6aguod2i

24 November 2022

mapped directly with Wikidata item

PubMed ID

16938363

1 reference

PubMed ID

16938363